CXCL5 drives obesity to diabetes, and further. - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Aging Year : 2009

CXCL5 drives obesity to diabetes, and further.

Abstract

We have recently shown that the CXCL5 chemokine is secreted by adipose tissue in the obese state. We demonstrated that adipose tissue-derived CXCL5 mediates insulin resistance in muscle. We speculate in this paper that CXCL5 could also mediate other obesity, and diabetes-derived pathologies, such as cardiovascular disease, retinopathy, or inflammatory bowel disease. In this scenario CXCL5 targeted therapy would prevent not only the development of type II diabetes in obese subjects, but also several other obesity-related co morbidities. Finally we propose to analyze the CXCL5 gene to find particular polymorphisms that could predict the development of type II diabetes in obese subjects.
Fichier principal
Vignette du fichier
schema.pdf (1.78 Mo) Télécharger le fichier
edited-CXCL5-aging-3.pdf (400.44 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Origin : Files produced by the author(s)

Dates and versions

inserm-00469840 , version 1 (02-04-2010)

Identifiers

Cite

Carine Chavey, Lluis Fajas. CXCL5 drives obesity to diabetes, and further.: CXCL5 and metabolism. Aging, 2009, 1 (7), pp.674-7. ⟨10.18632/aging.100064⟩. ⟨inserm-00469840⟩
124 View
353 Download

Altmetric

Share

Gmail Facebook X LinkedIn More